Preview Mode Links will not work in preview mode

Oct 15, 2020

Proceedings from a CME webinar held in partnership with the American Society of Clinical Oncology. Featuring perspectives from Dr Alexander E Drilon, Prof Solange Peters and Dr Suresh S Ramalingam on the following topics:

  • EGFR mutation-positive non-small cell lung cancer (NSCLC) (00:00)
  • NSCLC with ALK rearrangements (34:16)
  • RET fusion-positive disease (51:34)
  • Targeting MET in MET exon 14-altered disease (59:47)
  • HER2-mutant NSCLC (1:06:34)
  • NSCLC with ROS1 rearrangements (1:14:40)
  • Other targetable genetic abnormalities (1:20:43)

CME information and select publications